Clinical Practice Session
Resistant Hypertension: Newer Therapies
November 06, 2025 | 10:30 AM - 12:30 PM
Location: Grand Ballroom B, Convention Center
Session Description
This session reviews current practices and approaches to resistant hypertension, including preclinical and clinical data of newer therapies and proposed implementation.
ASN thanks the American Heart Association Council on the Kidney in Cardiovascular Disease for assistance with this session.
Learning Objective(s)
- Describe the mechanisms underlying resistant hypertension
- Identify patients with resistant hypertension and outline approaches to treatment
- Discuss newer therapies in the management of resistant hypertension
- Explain how to use new hypertension therapies in conjunction with standard of care
Learning Pathway(s)
- Hypertension and Cardiorenal Disorders
- Pharmacology
Moderators
Presentations
- Approach to Patients with Resistant Hypertension: What Is in Our Toolbox?
10:30 AM - 11:00 AM
- Aldosterone Synthase Inhibitors: New Kids on the Block
11:00 AM - 11:30 AM
- Endothelin Antagonists for Resistant Hypertension
11:30 AM - 12:00 PM
- RNA-Based Angiotensinogen Inhibitors: A Promising New Treatment?
12:00 PM - 12:30 PM